Fox Run Management L.L.C. acquired a new stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 7,946 shares of the business services provider's stock, valued at approximately $708,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Venturi Wealth Management LLC boosted its position in shares of Exponent by 4.6% during the fourth quarter. Venturi Wealth Management LLC now owns 2,531 shares of the business services provider's stock worth $226,000 after buying an additional 111 shares during the period. Heritage Family Offices LLP boosted its position in Exponent by 3.8% during the 4th quarter. Heritage Family Offices LLP now owns 3,123 shares of the business services provider's stock worth $278,000 after acquiring an additional 114 shares during the last quarter. Arizona State Retirement System grew its stake in shares of Exponent by 0.9% during the 4th quarter. Arizona State Retirement System now owns 14,723 shares of the business services provider's stock worth $1,312,000 after acquiring an additional 133 shares in the last quarter. Private Trust Co. NA raised its holdings in shares of Exponent by 129.8% in the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider's stock valued at $25,000 after purchasing an additional 157 shares during the last quarter. Finally, Pacer Advisors Inc. lifted its position in shares of Exponent by 2.4% in the fourth quarter. Pacer Advisors Inc. now owns 7,574 shares of the business services provider's stock worth $675,000 after purchasing an additional 180 shares in the last quarter. 92.37% of the stock is owned by institutional investors and hedge funds.
Exponent Stock Up 0.2 %
EXPO traded up $0.19 during trading hours on Friday, hitting $82.23. 289,130 shares of the company's stock were exchanged, compared to its average volume of 231,863. Exponent, Inc. has a 1-year low of $77.30 and a 1-year high of $115.75. The stock's 50-day moving average is $86.78 and its two-hundred day moving average is $95.75. The stock has a market cap of $4.18 billion, a price-to-earnings ratio of 38.79 and a beta of 0.77.
Exponent (NASDAQ:EXPO - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter in the prior year, the business posted $0.41 earnings per share. On average, equities research analysts anticipate that Exponent, Inc. will post 1.98 EPS for the current year.
Insider Buying and Selling at Exponent
In other Exponent news, VP Richard Reiss sold 1,736 shares of the stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total value of $149,174.48. Following the completion of the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. This trade represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 2.10% of the company's stock.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.